reference/25691961

Predicate	Object
contentType	Editorial\|Comment
endingPage	1491
issn	0263-6352
issueIdentifier	8
pageRange	1489-1491
publicationName	Journal of Hypertension
startingPage	1489
bibliographicCitation	Kjeldsen SE, Os I, Redon J. Treatment of hypertension and the price to pay; adverse events and discontinuation from randomized treatment in clinical trials. J Hypertens. 2016 Aug;34(8):1489–91. doi: 10.1097/hjh.0000000000001002. PMID: 27355995.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20ebb78cacdb67f1606514cb6bc0e7ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8777-6773 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10bf7577b87b6a09162935ddce3593ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_930b18d3e01f519cde56704a667e80fe
date	201608
identifier	https://doi.org/10.1097/hjh.0000000000001002 https://pubmed.ncbi.nlm.nih.gov/27355995
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4814 https://portal.issn.org/resource/ISSN/0263-6352
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Treatment of hypertension and the price to pay; adverse events and discontinuation from randomized treatment in clinical trials

Total number of triples: 21.